Marshall Wace, LLP Charles River Laboratories International, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 309,059 shares of CRL stock, worth $58.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

309,059

Previous 825,905 62.58%

Holding current value

$58.1 Million

Previous $171 Million 64.32%

% of portfolio

0.08%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $97.1 Million - $127 Million	-516,846 Reduced 62.58%	309,059 $60.9 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $33.7 Million - $43.8 Million	163,056 Added 24.6%	825,905 $171 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $135 Million - $181 Million	662,849 New	662,849 $180 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $59.3 Million - $66.4 Million	-305,047 Reduced 71.52%	121,479 $23.8 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $97.1 Million - $111 Million	-528,388 Reduced 55.33%	426,526 $89.7 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $15.4 Million - $20.8 Million	80,141 Added 9.16%	954,914 $193 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $62.9 Million - $79.8 Million	319,095 Added 57.42%	874,773 $191 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $39.3 Million - $54 Million	215,372 Added 63.29%	555,678 $109 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $34.2 Million - $50.6 Million	167,447 Added 96.87%	340,306 $72.8 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $72 Million - $102 Million	-281,936 Reduced 61.99%	172,859 $49.1 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $53.5 Million - $68.3 Million	152,258 Added 50.33%	454,795 $171 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $7.38 Million - $9.08 Million	19,810 Added 7.01%	302,537 $125 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $187 Million - $236 Million	-634,329 Reduced 69.17%	282,727 $105 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $16 Million - $19.2 Million	64,142 Added 7.52%	917,056 $266 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $8.8 Million - $10 Million	39,637 Added 4.87%	852,914 $213 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $127 Million - $163 Million	721,829 Added 789.33%	813,277 $184 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $10.9 Million - $17.3 Million	91,448 New	91,448 $15.9 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $19.9 Million - $35.9 Million	-201,547 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $10.1 Million - $12.3 Million	80,303 Added 66.23%	201,547 $30.8 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $6.44 Million - $7.39 Million	51,461 Added 73.74%	121,244 $16 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $7.69 Million - $9.25 Million	62,299 Added 832.43%	69,783 $9.9 Million
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $357,855 - $500,936	3,414 Added 83.88%	7,484 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $4.56 Million - $5.96 Million	-43,432 Reduced 91.43%	4,070 $461,000
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $5.33 Million - $6.39 Million	47,502 New	47,502 $6.39 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Charles River Laboratories International, Inc. Transaction History